Reminder – BioSig Subsidiary, ViralClear to Host Conference Call on June 9th to Discuss Upcoming and Recent Developments for Phase II Human Clinical Trials of its Broad-Spectrum Oral Anti-Viral Candidate for Treatment of COVID-19
Westport, CT, June 08, 2020 (GLOBE NEWSWIRE) —Company to provide updates on the initiation of human trials for treatment of […]